CIBC World Market
CRL icon

CIBC World Market’s Charles River Laboratories CRL Stock Holding History

CIBC World Market’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,226
Closed -$666K – 1322
2024
Q2 		$666K Buy
+3,226
New +$731K ﹤0.01% 885
2023
Q4 		– Sell
-2,192
Closed -$430K – 1256
2023
Q3 		$430K Buy
2,192
+286
+15% +$58.7K ﹤0.01% 942
2023
Q2 		$401K Buy
+1,906
New +$379K ﹤0.01% 978
2022
Q4 		– Sell
-2,068
Closed -$407K – 1264
2022
Q3 		$407K Buy
2,068
+286
+16% +$61.7K ﹤0.01% 934
2022
Q2 		$381K Buy
+1,782
New +$435K ﹤0.01% 953
2022
Q1 		– Sell
-875
Closed -$330K – 1331
2021
Q4 		$330K Sell
875
-11,176
-93% -$4.34M ﹤0.01% 1101
2021
Q3 		$4.97M Sell
12,051
-6,011
-33% -$2.5M 0.02% 367
2021
Q2 		$6.68M Buy
+18,062
New +$6.03M 0.02% 319

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

CIBC World Market's CRL Position: Q3 2024 in Review

CIBC World Market sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 3,226 shares — an estimated $666K sold.

CIBC World Market first reported a position in CRL in Q2 2021 and held it in 8 quarters. The position peaked at $6.68M in Q2 2021. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • CIBC World Market reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • CIBC World Market sold 3,226 Charles River Laboratories shares in Q3 2024, an estimated $666K.
  • CIBC World Market first reported a position in Charles River Laboratories in Q2 2021 and held it in 8 quarters.
  • CIBC World Market's Charles River Laboratories position peaked at $6.68M in Q2 2021.
  • 628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on CIBC World Market's 13F filing for Q3 2024, filed 12 Nov 2024.